Vista Pharmaceuticals Ltd. (BSE: 524711) is a Hyderabad, Telangana-based company in the Non-Prescription Drugs industry. With a market capitalisation of ₹36 Cr, it ranks #4,137 by market cap among the 6,189 Indian listed companies on FinBizNet, and #8 of 9 in Non-Prescription Drugs. At ₹5.84 (as of 26 Oct 2026), the share price is 44.0% below its 52-week high of ₹10.43 and 9.8% above its 52-week low of ₹5.32. The share price is down 37.7% over one year and down 19.7% over three months.
| Current Price | ₹5.84 |
|---|---|
| Market Cap | ₹36 Cr |
| BSE Code | 524711 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Non-Prescription Drugs |
| P/E Ratio | -7.4 |
| Return on Equity | -10.82% |
| Return on Assets | -4.89% |
| 52-Week Range | ₹5.32 – ₹10.43 |
| 1-Year Price Change | -37.7% |
| 3-Month Price Change | -19.7% |
| Beta (1Y) | 0.64 |
| Headquarters | Hyderabad, Telangana |
| Website | www.vistapharmaceuticals.com |
Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally. It offers over the counter and prescription generic drugs consisting of tablets, capsules, and liquids covering various therapeutic categories. The company was incorporated in 1991 and is based in Hyderabad, India.
1. Manufacturing of Pharmaceutical Products-This segment manufactures and sells pharmaceutical, medical, and veterinary preparations.
1. Manufacturing of Pharmaceutical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd. | ₹40,739 Cr | 39.3 | 48.91% | ₹938 Cr | -11.7% |
| Alembic Pharmaceuticals Limited (Aplltd) | ₹14,941 Cr | 22.1 | 12.36% | ₹2,150 Cr | -18.6% |
| Bliss Gvs Pharma Ltd. | ₹6,683 Cr | 52.4 | 11.60% | ₹286 Cr | +308.7% |
| Zota Health Care Ltd | ₹4,304 Cr | -55.3 | -16.05% | ₹174 Cr | -17.5% |
| Amrutanjan Health Care Ltd. | ₹1,410 Cr | 24.3 | 16.62% | ₹103 Cr | -30.3% |
| Jenburkt Pharmaceuticals Ltd. | ₹380 Cr | 10.9 | 18.84% | — | -11.8% |
| Sat Kartar Life Limited | ₹205 Cr | 12 | — | — | — |
| Vista Pharmaceuticals Ltd. | ₹36 Cr | -7.4 | -10.82% | — | -37.7% |
| Welcure Drugs & Pharmaceuticals | ₹22 Cr | -4.5 | -5.50% | — | -75.6% |
Listed by market capitalisation. Ratios are shown for context only.
Vista Pharmaceuticals Ltd. is trading at ₹5.84, with a market capitalisation of ₹36 Cr.
Vista Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Non-Prescription Drugs).
Vista Pharmaceuticals Ltd. has a P/E of -7.4 and a return on equity of -10.82%.
Vista Pharmaceuticals Ltd. is listed on the BSE under the scrip code 524711.
Vista Pharmaceuticals Ltd.'s share price is down 37.7% over one year and down 19.7% over three months. Its 52-week range is ₹5.32 to ₹10.43.
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.